EUVIMEDEUVIMED entdecken
Kommentar

In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

Andrew Dunn

Annals of Internal Medicine · 2024

DOI: 10.7326/j24-0024 ↗

Kurz gefasst

Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Andrew Dunn. Beteiligte Einrichtung: Icahn Mount Sinai School of Medicine, New York, NY, USA (A.D.). Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Hemorrhage, Vitamin K. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationHemorrhageVitamin KAgedAged, 80 and overFemaleHumansMaleDrug SubstitutionFrail ElderlyFrailtyStrokeRandomized Controlled Trials as Topic

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Icahn Mount Sinai School of Medicine, New York, NY, USA (A.D.).

Zitieren

APA

Dunn, A. (2024). In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Annals of Internal Medicine. https://doi.org/10.7326/j24-0024

Vancouver

Dunn A. In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Annals of Internal Medicine. 2024. doi:10.7326/j24-0024

BibTeX
@article{Dunn2024,
  author = {Dunn, Andrew},
  title = {In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/j24-0024}
}
Kostenlos starten →